Cystic Fibrosis Liver Disease and Ursodeoxycholic Acid: One Small Step Forward, Miles to Go

被引：0
|
作者：
Narkewicz, Michael R. [1 ]
机构：
[1] Univ Colorado, Dept Pediat, Sect Pediat Gastroenterol Hepatol & Nutr, Childrens Hosp Colorado,Digest Hlth Inst,Sch Med, Aurora, CO USA
来源：
JOURNAL OF PEDIATRICS | 2016年 / 177卷
关键词：
MANAGEMENT;
D O I：
10.1016/j.jpeds.2016.06.020
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：17 / 18
页数：3
相关论文
共 50 条
  • [21] A CONTROLLED TRIAL OF URSODEOXYCHOLIC ACID TREATMENT IN CYSTIC FIBROSIS-RELATED LIVER-DISEASE
    OBRIEN, S
    FITZGERALD, MX
    HEGARTY, JE
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1992, 4 (10) : 857 - 863
  • [22] Ursodeoxycholic acid for liver disease associated with cystic fibrosis: A double-mind multicenter trial
    Colombo, C
    Battezzati, PM
    Podda, M
    Bettinardi, N
    Giunta, A
    HEPATOLOGY, 1996, 23 (06) : 1484 - 1490
  • [23] URSODEOXYCHOLIC ACID FOR CYSTIC FIBROSIS-ASSOCIATED LIVER-DISEASE - FINAL REPORT OF A MULTICENTER TRIAL
    COLOMBO, C
    PODDA, M
    BATTEZZATI, PM
    SANTINI, B
    IAPICHINO, L
    QUATTRUCCI, S
    LUCIDI, V
    FERRARI, R
    SCOTTA, S
    MINICUCCI, L
    CANDUSSO, M
    VALLETTA, E
    GAGLIARDINI, R
    SANTAMARIA, F
    BATTISTINI, F
    GIUNTA, A
    HEPATOLOGY, 1993, 18 (04) : A142 - A142
  • [24] Ursodeoxycholic acid treatment is associated with improvement of liver stiffness in cystic fibrosis patients
    van der Feen, Cathelijne
    van der Doef, Hubert P. J.
    van der Ent, Cornelis K.
    Houwen, Roderick H. J.
    JOURNAL OF CYSTIC FIBROSIS, 2016, 15 (06) : 834 - 838
  • [25] URSODEOXYCHOLIC TREATMENT IN PATIENTS WITH CYSTIC-FIBROSIS AND ASSOCIATED LIVER-DISEASE
    GALABERT, C
    LENGRAND, D
    MONTET, JC
    DIMIER, JL
    CHAZALETTE, JP
    PATHOLOGIE BIOLOGIE, 1991, 39 (06): : 625 - 628
  • [26] Natural Language Processing and the Promise of Big Data Small Step Forward, but Many Miles to Go
    Maddox, Thomas M.
    Matheny, Michael A.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2015, 8 (05): : 463 - 465
  • [27] Clinical outcome of long-term treatment of ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease
    Colombo, C
    Crosignani, A
    Comi, S
    Arban, D
    Giunta, A
    BILE ACIDS IN HEPATOBILIARY DISEASES: BASIC RESEARCH AND CLINICAL APPLICATION, 1997, 93 : 318 - 322
  • [28] Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease
    Nousia-Arvanitakis, S
    Fotoulaki, M
    Economou, H
    Xefteri, M
    Galli-Tsinopoulou, A
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 32 (04) : 324 - 328
  • [29] URSODEOXYCHOLIC ACID THERAPY IN CYSTIC-FIBROSIS ASSOCIATED LIVER-DISEASE - A DOSE-RESPONSE STUDY
    COLOMBO, C
    CROSIGNANI, A
    ASSAISSO, M
    BATTEZZATI, PM
    PODDA, M
    GIUNTA, A
    ZIMMERNECHEMIAS, L
    SETCHELL, KDR
    HEPATOLOGY, 1992, 16 (04) : 924 - 930
  • [30] A step forward for an intermediate cystic fibrosis population
    Birket, Susan E.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60 (02)
12345